Skip to main content
Molecular Syndromology logoLink to Molecular Syndromology
. 2026 Jan 7;17(3):307–308. doi: 10.1159/000549839

Erratum

PMCID: PMC12779303  PMID: 41510140

In the article “Clinical and Radiological Profile of Nine Patients with Metachromatic Leukodystrophy” [Mol Syndromol. 2025;16(2):138–151. https://doi.org/10.1159/000540925] by Kasapkara et al., there was a typographical error in both the text relating to patient 7 and in Table 1.

Under the heading Patient 7 the seventh sentence reads:

“The ASA activity was 8.5 nmol/mg-17 h (normal activity >45), and a homozygous c.960G>T (p.Trp320*) mutation was revealed in the ARSA gene.”

It should read:

“The ASA activity was 8.5 nmol/mg-17 h (normal activity >45), and a homozygous c.960G>T (p.Trp320Cys) mutation was revealed in the ARSA gene.”

In addition, there was a typographical error in Table 1 in the row relating to the Molecular Analyses of ARSA gene of Patient 7, which read “c.960 G>T (p.Trp320a)” but should read “c.960 G>T (p.Trp320Cys).” The corrected table is shown below.

Table 1.

General demographics and characteristics of all patients

Patient no. Current age, months Gender Consanguinity Antenatal/natal history Onset symptoms Age at symptom onset, months Age at diagnosis, months MLD type Baseline ASA activity (nmol/h/mgprt) (>5) Post-HSCT ASA activity (nmol/h/mgprt) (>5) Molecular analyses of ARSA gene
1 67 F + Full-term, 3,600 g Difficulty walking and swallowing 20 30 LI 0.31 ​ c.418dupC (p.His140ProfsTer36)
2 41 F + Full-term, 3,500 g – – 3 LI 2.5 7.33 c.418dupC (p.His140ProfsTer36)
3 65 M + 35 GW, twin pregnancy, 2,600 g Difficulty walking and spasticity 18 30 LI 0 ​ c.736C>T (p.Arg246Cys)
4 70 F + Full-term, 3,000 g Difficulty walking and swallowing 25 35 LI 7.8a ​ c.583delT (p.Trp195GlyfsTer5)
5 72, exitus F + NDA NDA NDA 56 LI 0.46 ​ c.1167_1168insT (p.Ala390CysfsTer20)
6 51 M + Full-term, 3,150 g Difficulty walking and frequent falls 20 23 LI 4.26 ​ c.1167_1168insT(p.Ala390CysfsTer20)
7 52 M + Full-term, 3,450 g Difficulty walking 22 25 LI 8.5a ​ c.960 G>T (p.Trp320Cys)
8 84 F + Full-term, 3,500 g Neurodevelopmental regression 60 73 J 0.30 ​ c.640G>A (p.Ala214Thr)
9 47 F + Full-term, 3,150 g – – 36 J 0.20 26.17 c.640G>A (p.Ala214Thr)

GW, gestational weeks; M, male; F, female; ASA, arylsulfatase A enzyme; LI, late infantile; J, juvenile.

aARSA dried blood spot (DBS), normal range 45–260 nmol/h/mL.


Articles from Molecular Syndromology are provided here courtesy of Karger Publishers

RESOURCES